Athersys Inc (OTCPK:ATHXQ)
$ 0.0001 0 (0%) Market Cap: 6,000.00 Enterprise Value: 17.56 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 0/100

Athersys Inc at Bank of America Healthcare Conference Transcript

May 11, 2022 / 11:00PM GMT
Release Date Price: $14.53 (-11.85%)
Gregory Allen Harrison
BofA Securities, Research Division - Analyst

Welcome to the afternoon session of day 2 of the Bank of America Healthcare Conference. My name is Greg Harrison. I'm one of the biotech analysts here at Bank of America. It's my pleasure today to introduce Dan Camardo, Chief Executive Officer of Athersys; and Ivor Macleod, Chief Financial Officer.

Dan, would you like to start off with some opening remarks, and then we can jump into Q&A?

Daniel A. Camardo
Athersys, Inc. - CEO & Director

Sure. Thanks, Greg. Thanks for having us. And for myself and Ivor and the rest of the team at Athersys, this is an important day but also leading to an important milestone that we're working towards coming up in the next few weeks regarding an output of our partner's Phase III trial results in stroke called the TREASURE trial.

I think that just from the other companies that I've seen here, I would probably say Athersys might be one of the most unknown stories that are out here visiting in Las Vegas. And I think we have a really

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot